Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02116582
What this trial is testing

Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Europe B.V. 215
Early research (Phase 1)WithdrawnNCT02380313
What this trial is testing

Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone

Who this might be right for
Cancer
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT01549951
What this trial is testing

Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT02407054
What this trial is testing

Enzalutamide and LY3023414 in Men With Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Eli Lilly and Company 142
Early research (Phase 1)Ended earlyNCT04227275
What this trial is testing

CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 16
Large-scale testing (Phase 3)Study completedNCT01517802
What this trial is testing

A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Breast Cancer
Janssen Research & Development, LLC 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02807805
What this trial is testing

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 37
Early research (Phase 1)Active Not RecruitingNCT03873805
What this trial is testing

PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8+2 more
City of Hope Medical Center 14
Early research (Phase 1)Study completedNCT02924766
What this trial is testing

A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 34
Early research (Phase 1)Looking for participantsNCT07719361
What this trial is testing

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate CancermCRPCmCRPC (Metastatic Castration-resistant Prostate Cancer)+6 more
Flare Therapeutics Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT03522064
What this trial is testing

Bipolar Androgen Therapy + Carboplatin in mCRPC

Who this might be right for
Castration-resistant Prostate CancerHomologous Recombination Deficiency
St Vincent's Hospital, Sydney 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890832
What this trial is testing

Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, MCRPC
Jina Pharmaceuticals Inc. 75
Not applicableStudy completedNCT02663193
What this trial is testing

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Who this might be right for
Prostate Cancer
Janssen Scientific Affairs, LLC 108
Early research (Phase 1)Study completedNCT06136598
What this trial is testing

Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)

Who this might be right for
Prostatic NeoplasmsMetastatic Castration-Resistant Prostate Cancer
Merck Sharp & Dohme LLC 14
Very early researchEnded earlyNCT04116164
What this trial is testing

Safety and Targeting of Anti-hk2 Antibody in mCRPC

Who this might be right for
Castration-Resistant Prostatic CancerMetastatic Disease
SpectronRX 27
Testing effectiveness (Phase 2)Looking for participantsNCT07590934
What this trial is testing

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 152
Early research (Phase 1)Study completedNCT03074032
What this trial is testing

Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Avionco LLC 17
Testing effectiveness (Phase 2)Study completedNCT02099864
What this trial is testing

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
OHSU Knight Cancer Institute 36
Not applicableLooking for participantsNCT06720532
What this trial is testing

Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial

Who this might be right for
Kidney DiseaseRadiation NephropathyMetastatic Castrate Resistant Prostate Cancer (mCRPC)
Hannah Schaefer 100
Testing effectiveness (Phase 2)Study completedNCT01595087
What this trial is testing

A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer Metastatic
DexTech Medical AB 28
Next Page